DVA today
$174.07-$9.43 (-5.14%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourStrong Bearish
15 minBearish
5 minDescending Triangle
Daily trend turns up above $195.75
Key levels
Resistance$196.97
Resistance$182.60
Support$171.09
Support$157.18
Latest news & SEC filings
LegalLawsuit accuses DaVita and Fresenius of blocking competition in Washington
AnalystUBS keeps Buy rating on DaVita, lifts price target to $287
AnalystBarclays keeps Equal-Weight rating on DaVita, cuts price target to $216
All DVA news →About DaVita
DaVita is a healthcare provider specializing in kidney care. It operates outpatient dialysis centers in the United States and internationally, offering hemodialysis, peritoneal dialysis, and home-based treatments. The company also provides integrated kidney care management and laboratory services. Its patients include those with chronic kidney failure and end-stage kidney disease, covered by government programs and commercial insurers.
Based on the company's 10-K filed Feb 11, 2026.
NYSE · Healthcare
DAVITA INC. (DVA)
What Is the Price Target for DVA?
SEPT Low Target
$215.00
SEPT Mid Target
$224.00
SEPT High Target
$270.00
Analyst Consensus
$224.00
Is DVA a Buy or Sell Right Now?
Thesis
- •Revenue growing 6.5% YoY with STABLE trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DVA.
Start Free Trial →Is DVA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$235.64
20
Moat Score
NONE
6/9
Piotroski Score
1.7
Altman Z-Score
What Is Smart Money Doing with DVA?
Insider Signal
SELLING
0 buys / 7 sells (90d)
Congress Signal
BUYING
1 buys / 1 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| BERKSHIRE HATHAWAY INC | 10% owner | Sale | 382,563 | $69.0M | Oct 27, 2026 |
| Maughan David Paul | officer | Sale | 7,501 | $1.4M | Sep 22, 2026 |
| BERKSHIRE HATHAWAY INC | 10% owner | Sale | 182,980 | $36.5M | Jul 31, 2026 |
| YALE PHYLLIS R | director | Sale | 5,038 | - | May 26, 2026 |
| Pullin Dennis W | director | Buy | 250 | - | May 15, 2026 |
| Moore Gregory J. | director | Buy | 250 | - | May 15, 2026 |
| Schoppert Wendy Lee | director | Buy | 250 | - | May 15, 2026 |
| Arway Pamela M | director | Buy | 250 | - | May 15, 2026 |
| YALE PHYLLIS R | director | Buy | 250 | - | May 15, 2026 |
| DESOER BARBARA J | director | Buy | 250 | - | May 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →DVA Growth Story
Revenue YoY
6.5%
3yr Revenue CAGR
5.5%
EPS Growth YoY
-8.29%
FCF Growth YoY
-10.6%
Revenue Trend
STABLE
Dark Pool Trades for DVA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for DVA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:01:10 | $174.07 | 1,800 | $$313K | SELL |
| 21:01:10 | $174.07 | 4,038 | $$703K | SELL |
| 21:01:10 | $174.07 | 2,785 | $$485K | SELL |
| 20:54:43 | $174.92 | 1,100 | $$192K | SELL |
| 20:11:04 | $176.09 | 4,033 | $$710K | BUY |
5 dark pool trades shown · $$2.4M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for DVA
PREVIEWSEPT Investing provides real-time options flow tracking for DVA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $105 | Dec 18 | 36 | $$7700 | 1 | SWEEP |
| CALL | $185 | Jan 19 | 799 | $$4510 | 1 | SWEEP |
| CALL | $185 | Jan 19 | 799 | $$4470 | 1 | SWEEP |
| CALL | $185 | Jan 19 | 799 | $$4530 | 1 | SWEEP |
| CALL | $185 | Jan 19 | 799 | $$9004 | 2 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for DAVITA INC. (DVA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DVA — frequently asked questions
What is DVA stock price today?
DAVITA INC. (DVA) is at $174.07, down 5.14% (-$9.43) at the Nov 12, 2026 close.
Why is DVA stock moving today?
Latest DVA news — Nov 12, 2026: Lawsuit accuses DaVita and Fresenius of blocking competition in Washington · Nov 2, 2026: UBS keeps Buy rating on DaVita, lifts price target to $287
What is the DVA price target?
The average analyst price target for DVA is $224.00, ranging from $215 to $270, based on 6 analysts.
What do analysts rate DVA?
Analyst ratings for DVA: 2 Buy, 9 Hold, 0 Sell — consensus Hold.
Did DVA beat earnings?
DVA last reported on Oct 29, 2026: EPS $3.82 vs $3.57 expected — a beat of 7.0%.
What is DVA's P/E ratio?
DVA trades at a P/E of 13.9 vs a Healthcare average of 18.4.
Does DVA pay a dividend?
DVA does not currently pay a dividend.
How much debt does DVA have?
DAVITA INC. reported $10.7B of debt and $496M of cash (Sep 30, 2026).
What are DVA support and resistance levels?
Support: $171.09, $157.18, $149.35. Resistance: $182.60, $196.97, $206.85.
What are insiders doing with DVA?
Insider activity: SELLING, 0 buys and 7 sells in the last 90 days.
What is the latest news on DVA?
Nov 12, 2026: Lawsuit accuses DaVita and Fresenius of blocking competition in Washington · Nov 2, 2026: UBS keeps Buy rating on DaVita, lifts price target to $287 · Nov 2, 2026: Barclays keeps Equal-Weight rating on DaVita, cuts price target to $216